β-hCG promotes epithelial ovarian cancer metastasis through ERK/MMP2 signaling pathway

Abstract

Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy, with typically extensive intraperitoneal implantation leading to poor prognosis. Our previous study preliminarily demonstrated β-hCG can promote tumorigenesis in immortalized nontumorigenic ovarian epithelial cells. In this study, the roles and mechanisms of β-hCG in regulating EOC proliferation and metastasis were thoroughly explored. First, histologically, β-hCG was aberrantly overexpressed in human EOC metastatic tissues, and significantly correlated with FIGO stage, tumor size, differentiation, histologic grade and high grade serous ovarian carcinoma (HGSOC) (P < 0.05). However, serologically, β-hCG expression showed no significant difference between EOC and nonmalignant ovarian patients. Second, β-hCG was confirmed to have no significant effects on EOC proliferation in vitro and in vivo, while β-hCG upregulation was proven to promote migration and invasion ability in ES-2 and OVCAR-3 cells in vitro (P < 0.05), and β-hCG downregulation in SKOV3 cells had the opposite effect. Moreover, more invadopodia protrusions, mitochondria accumulations and cytoskeletal rearrangements were observed in β-hCG-overexpressing ES-2 cells, while β-hCG-depleted SKOV3 cells produced the opposite effect. Furthermore, β-hCG was confirmed to clearly facilitate intraperitoneal metastasis in nude mouse orthotopic ovarian xenograft models. Importantly, these effects of β-hCG were mediated by activation of the ERK/MMP2 signaling pathway, independently of luteinizing hormone/chorionic gonadotropin receptor (LHCGR) presence, and inhibition the pathway with the p-ERK1/2 inhibitor SCH772984 significantly impaired the tumor-promoting effects induced by β-hCG. Collectively, these data provide new insight into the roles and mechanisms of β-hCG in regulating EOC metastasis through ERK/MMP2 signaling pathway and may become a new target for therapeutic intervention.

RETRACTED ARTICLE: Long noncoding RNA MAGI1-IT1 promoted invasion and metastasis of epithelial ovarian cancer via the miR-200a/ZEB axis

“…Immunohistochemistry (IHC) was performed as previously described [22]. Briefly, 4-μm-thick tissue sections were stained with primary polyclonal antibodies against E-cadherin, N-cadherin, β-catenin, ZEB1 (1:200, Cat.9782, Cell Signaling Technology, USA), and ZEB2 (1:200, cat.…”

Cancer Stem Cell Transcriptome Landscape Reveals Biomarkers Driving Breast Cancer Heterogeneity

“…This is consistent with the pathway analysis and suggests the prominent roles of uncontrolled proliferation and increased migration ability in CSC feature initiation and maintenance. VIM [42], MMP2 [43], FGF2 [44], ITBG3 [45,46], ANXA6 [47] are metastasis-associated genes. The oncogenic roles of KCNMA1 has been revealed in breast, prostate, ovarian and colorectal cancers [48][49][50][51][52], and RRAD is associated with glucose uptake in a human ovarian cancer model [53] and implicated in non-small cell lung cancers [54].…”

Disease Associated Protein-Protein Interaction Network Reconstruction Based on Comprehensive Influence Analysis

“…MMP2 is a protease capable of degrading collagen and the extracellular matrix and involved in tumor-cell infiltration of connective tissue stroma, small blood vessels, and lymphatic tissue [45]. Additionally, MMP2 is highly expressed in prostate cancer tissues and plays a role similar to that of proto-oncogenes, as attenuated MMP2 levels inhibit tumor-cell proliferation, invasion, and migration and promote apoptosis, thereby alleviating tumor malignancy.…”